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The hypoxia-inducible factor (HIF) family of transcription factors
directs a coordinated cellular response to hypoxia that includes
the transcriptional regulation of a number of metabolic enzymes.
Chuvashpolycythemia (CP) is anautosomal recessive humandisorder
in which the regulatory degradation of HIF is impaired, resulting in
elevated levels of HIF at normal oxygen tensions. Apart from the
polycythemia, CP patients have marked abnormalities of cardiopul-
monary function. No studies of integrated metabolic function have
been reported. Here we describe the response of these patients to
a series of metabolic stresses: exercise of a large muscle mass on
a cycle ergometer, exercise of a smallmusclemass (calfmuscle)which
allowednoninvasive in vivoassessments ofmusclemetabolismusing
31P magnetic resonance spectroscopy, and a standardmeal tolerance
test. During exercise, CP patients had early and marked phosphocre-
atine depletion and acidosis in skeletal muscle, greater accumulation
of lactate in blood, and reducedmaximumexercise capacities.Muscle
biopsy specimens from CP patients showed elevated levels of tran-
script for pyruvate dehydrogenase kinase, phosphofructokinase,
and muscle pyruvate kinase. In cell culture, a range of experimental
manipulations have been used to study the effects of HIF on cellular
metabolism. However, these approaches provide no potential to in-
vestigate integrated responses at the level of the whole organism.
AlthoughCPis relativelysubtledisorder,ourstudynowrevealsastrik-
ing regulatory role for HIF onmetabolism during exercise in humans.
These ﬁndings have signiﬁcant implications for the development of
therapeutic approaches targeting the HIF pathway.
exercise | lactate | glycolysis | Chuvash polycythemia | von Hippel-Lindau
The hypoxia-inducible factor (HIF) family of transcriptionfactors plays a key role in orchestrating the cellular response to
varying levels of oxygen. These transcription factors are hetero-
dimeric proteins consisting of two subunits: an oxygen-regulated
HIF-α subunit (HIF-1α, HIF-2α, or HIF-3α) and a constitutive
HIF-β subunit (1). At physiological levels of oxygen, HIF-α sub-
units undergo rapid degradation, limiting the formation of the
transcription complex (2). Degradation is initiated by hydroxyl-
ation of HIF-α protein by speciﬁc prolyl hydroxylases (3–5). This
hydroxylation enables binding of the von Hippel–Lindau (VHL)
protein (6, 7) and the subsequent destruction of HIF-α by the
ubiquitin–proteasome system. At low levels of oxygen, the rate of
hydroxylation of HIF-α is reduced. This reduction impairs the
binding of VHL to HIF-α, enabling accumulation of transcrip-
tionally active HIF complexes within the cell.
Many HIF target genes have been identiﬁed in metabolic and
other cellular functions (for review see refs. 8–10). In metabo-
lism, an early ﬁnding was a role for HIF in the transcriptional
regulation of genes encoding enzymes of the glycolytic pathway
(11). Subsequent experiments in cell culture also have identiﬁed
a role for HIF in (i) downregulating mitochondrial oxygen
consumption by directly or indirectly inducing pyruvate de-
hydrogenase kinase (PDK), which inhibits the mitochondrial
pyruvate dehydrogenase complex (PDC) from converting pyru-
vate into acetyl-CoA (12–14); (ii) regulating the differential ex-
pression of cytochrome c oxidase subunit 4 isoforms to optimize
the efﬁciency of respiration at different O2 tensions (15), and
(iii) inducing mitochondrial autophagy as an adaptive response
to hypoxia (16). However, these observations thus far have been
restricted mainly to cell culture, and their signiﬁcance (or lack
thereof) for the intact organism remains largely unexplored.
In humans, an opportunity to understand the effects of altered
HIF physiology on integrated metabolic function is afforded by
the condition of Chuvash polycythemia (CP). CP is an autosomal
recessive disorder that is endemic to the region of Chuvashia
(17) in the central European part of Russia. Individuals affected
with CP have a homozygous germline mutation in exon 3 of the
VHL gene (VHL 598C→T), which impairs the binding of the
gene product VHL to HIF-α subunits. This impairment reduces
the rate of HIF-α degradation and results in the stabilization of
the HIF complex and increased expression of HIF-target genes
under normoxic conditions (18, 19). Studies of patients with CP
have revealed high hematocrit and hemoglobin values, elevated
pulmonary arterial blood pressures, reduced systemic arterial
pressures, and marked increases in the sensitivity of the re-
spiratory system and the pulmonary vasculature to acute expo-
sures to hypoxia (17, 18, 20). However, no metabolic measures
have been reported in any of these studies.
In this study, we set out to determine whether any abnor-
malities of metabolism in patients with CP could be detected by
exposing patients to the metabolic stress of exercise and of
a standardized meal. In particular, we measured overall exercise
capacity through an incremental exercise test on a cycle er-
gometer; calf muscle energy metabolites during light exercise by
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means of 31P magnetic resonance spectroscopy (MRS); the
metabolic response (arterial and venous blood metabolites) to
the consumption of a standardized meal; and in vitro skeletal
muscle ﬁber composition, enzyme activities, and mRNA ex-
pression levels from biopsy samples obtained at rest. The results
demonstrate that, under conditions of enhanced metabolic ac-
tivity, CP patients generate substantially more lactate than con-
trol participants. Some, but not all, of the effects predicted from
studies of the HIF system in cell culture were observed in vivo in
humans who had CP.
Results
The age, sex, height, weight, body mass index, amount of physical
exercise per week, and hematocrit for the CP patients and con-
trol participants are given in Table 1. Control participants were
well matched for levels of physical activity in their daily life, body
mass index, and age.
CP Increases Lactate Production During Exercise and Limits Overall
Exercise Capacity. Fig. 1 illustrates mean values for venous blood
lactate concentration, end-tidal partial pressure of carbon di-
oxide, and ventilation as a function of work rate during the in-
cremental exercise test. Venous blood lactate concentration
increased early in the CP patients, becoming signiﬁcantly higher
than in the control group at ∼4 min into the exercise test at
a work rate of 80 W. CP patients stopped exercising at lower
work rates than controls. The maximum work rates achieved per
kg of body mass (reported in Table 1) were signiﬁcantly lower for
the CP patients, around 70% of those achieved by the control
participants. There was no correlation between maximum work
rate and hematocrit in the CP group. The end-tidal partial
pressure of carbon dioxide was signiﬁcantly lower in the CP
group at rest and remained so throughout the exercise protocol.
Furthermore, ventilation rose more rapidly during exercise in the
CP patients than in the control participants.
CP Causes Marked Phosphocreatine Depletion, Inorganic Phosphate
Elevation, and Fall in pH During Calf Muscle Exercise. Fig. 2 illus-
trates 31P MR spectra for a representative control participant
and a representative CP patient at rest and during calf exercise.
At rest, the spectra from the two individuals appeared similar.
However, during exercise, the phosphocreatine (PCr) peak al-
most disappeared, and the inorganic phosphate (Pi) peak was
markedly higher in the CP patient than in the control participant.
Similar results were obtained in all subjects within each group.
Mean values for PCr, Pi, and pH for the CP and for the control
groups during the three periods of calf exercise and intervening
periods of rest are shown in Fig. 3. In the CP group, marked
depletion of muscle PCr and elevation of Pi was evident even
at the lowest level of exercise. These effects were signiﬁcant at
all work rates, and even the lightest work rate (3 W) caused
a greater depletion of PCr and elevation of Pi in the CP group
than did the heaviest work rate (5 W) in the control group.
Similarly, at all three levels of exercise, the fall in muscle pH in
the CP group far exceeded the fall in muscle pH in the control
participants. Again, this effect was such that the fall in pH at the
lowest level of exercise in the CP group greatly exceeded the fall
in pH at even the heaviest level of exercise in the control group.
Muscle ATP concentration decreased in both groups in response
to exercise, but its concentration did not differ signiﬁcantly be-
tween the two groups at any level of exercise.
CP Is Associated with Elevated mRNA Levels of Muscle Phospho-
fructokinase, Muscle Pyruvate Kinase, and PDK in Skeletal Muscle.
Protein expression levels for the isoforms of myosin heavy chain,
indicative of muscle ﬁber composition, are shown in Fig. S1. No
signiﬁcant differences were found between the CP group and
the control group for the proportions of type I, IIA, IIX, and
IIB ﬁbers.
No signiﬁcant differences were detected in muscle glycogen
concentration, PDC total activity (PDCt), glutamate dehydrogenase
(GluDH), citrate synthase (CS), 3-hydroxyacyl-CoAdehydrogenase
(HAD), glyceraldehyde 3 phosphate dehydrogenase (GlyPDH),
myosin heavy chains, and myosin light chains in control participants
and CP patients (Table 2).
At the mRNA level, a signiﬁcant increase in CP patients’
transcript levels was observed for muscle phosphofructokinase
(PFKM), muscle pyruvate kinase (PKM) isoforms M1 (M1-PKM)
and M2 (M2-PKM), and PDK isoforms 1 (PDK1), 2 (PDK2), and
4 (PDK4) (Table 3). Transcript levels did not differ signiﬁcantly
for hexokinase isoforms 1 (HK1) and 2 (HK2), pyruvate de-
hydrogenase phosphatase isoforms 1 (PDP1) and 2 (PDP2), py-
ruvate dehydrogenase kinase isoform 3 (PDK3), and lactate
dehydrogenase A (LDHA).
CP Alters Pyruvate and Lactate Concentrations in Blood During the
Digestion of a Standard Meal. Fig. S2 illustrates the changes in
mean arterial concentrations for plasma glucose, plasma insulin,
plasma pyruvate, and blood lactate following the standard meal
tolerance test. The changes in glucose and insulin did not differ
Table 1. Individual and group characteristics of Chuvash polycythemia patients and control participants
Participant Age (y) Sex
Height
(m)
Weight
(kg)
Body mass
index (kg m−2)
Exercise per
week (h)
Maximum work
rate (W/kg)
Hematocrit
(%)
Control #1 22 M 1.80 79 24 <3 3.5 42
Chuvash #1 21 M 1.77 58 19 <3 3.1 62
Control #2 22 M 1.83 72 21 <3 4.2 45
Chuvash #2 22 M 1.71 65 22 <3 2.5 64
Control #3 24 M 1.77 75 24 <3 3.7 45
Chuvash #3 25 M 1.72 61 21 <3 3.3 41
Control #4 44 F 1.71 67 23 <3 3.3 36
Chuvash #4 34 F 1.52 69 30 <3 1.4 48
Control #5 46 F 1.61 65 25 <3 2.2 39
Chuvash #5 38 F 1.63 52 20 <3 1.5 41
Mean control 32 1.74 72 23 <3 3.4 42
SD Control 12 0.09 6 2 0.8 4
Mean Chuvash 28 1.67 61 22 <3 2.4* 51
SD Chuvash 8 0.10 6 4 0.9 11
Age, sex, height, weight, body mass index, amount of physical exercise per week, maximum work rate achieved during the incremental test on the cycle
ergometer, and hematocrit.
*The results for the CP group are signiﬁcantly different (P < 0.05) from those for the control group.
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signiﬁcantly between the CP group and the control group.
However, the increases in plasma pyruvate and blood lactate
60 min after ingestion of the standardized meal were signiﬁcantly
greater in the CP group than in the control group. At 60 min, the
plasma pyruvate concentration was 251 ± 64 μM (mean ± SD) in
the CP group compared with 122 ± 51 μM in the control group,
and the blood lactate was 1.74 ± 0.27 mM in the CP group
compared with 0.87 ± 0.37 mM in the control group.
Fig. S2 illustrates forearm blood ﬂow during the standard meal
tolerance test. No signiﬁcant effects of the meal were detected,
nor were there any signiﬁcant differences between the CP group
and the control group. Also illustrated in Fig. S2 are the uptakes
of glucose and lactate by skeletal muscle. These uptakes in-
creased after the meal. With the exception of one data point, no
signiﬁcant differences were detected between the CP group and
the control group.
Discussion
This study demonstrates that a functional mutation within the
HIF–VHL pathway can have a signiﬁcant effect on human en-
ergy metabolism at the level of the organism as a whole. In
particular, the study demonstrates that exercise, whether in-
volving a large or a small muscle mass, is a substantial metabolic
stress for patients with CP, who exhibit signiﬁcantly greater lactate
accumulation than normal controls. Compared with normal con-
trols, CP patients had low maximum exercise capacities and dem-
onstrated early and greater PCr depletion and acidosis during
a light ankle plantar-ﬂexion exercise. In patients with CP, skel-
etal muscle mRNA expression levels at rest were elevated for
enzymes of glycolysis and PDC inhibition.
In normal healthy volunteers, maximal oxygen uptake capacity
is a signiﬁcant determinant of both themaximum exercise capacity
and the work rate at which blood lactate begins to rise (21). In
patients with CP a degree of pulmonary hypertension (20) could
limit the rise in cardiac output with exercise and so cause low
maximum exercise capacity and early lactate production from
muscle. We did not record pulmonary arterial blood pressure in
this study and so do not know how much it may have risen during
the incremental exercise test. However, we studied energy me-
tabolism in a small muscle mass during light exercise, in which CP
patients demonstrated a striking depletion of PCr in muscle, ac-
cumulation of Pi, and marked muscle acidosis compared with the
normal controls. Because these ﬁndings were associated with light
exercise of a smallmusclemass, they suggest that cardiopulmonary
limitations to the delivery of oxygen are an unlikely explanation for
the abnormal metabolism. The light level of exercise also makes it
unlikely that the results are caused by diffusional limitations for
oxygen within the muscle. Finally, three of the ﬁve patients were
not noticeably polycythemic (because of clinical management via
venesection), and therefore viscosity changes in blood are not
likely to have limited the supply of oxygen. This last point is sup-
ported by the absence of any correlation between hematocrit and
maximum work rate in the CP group.
Skeletal muscle that contains a high proportion of fast-twitch
(type II) white muscle ﬁbers is more likely to metabolize anaero-
bically during exercise and so produce more lactate and have
greater PCr depletion at the onset of contraction. Thus a further
possibility is that the skeletal muscle of CP patients may contain
A Rest - Control
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ATP
αγ β
10 0 -10 -20 ppm
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Fig. 2. Examples of spectra obtained from calf muscle during 31P MRS.
(A andB) Spectra for a representative control participant. (C andD) Spectra for
a representative CP patient. (A and C) Spectra recorded at rest. (B and D)
Spectra recorded in the last minute of the 5-W exercise period. The depletion
of PCr and increase in Pi with exercise was much more marked in the Chuvash
patient than in the control participant.
Fig. 1. Responses of CP patients and control participants to incremental
exercise on a cycle ergometer. (A) Venous blood lactate concentration, (B)
end-tidal partial pressure of carbon dioxide (PCO2), and (C) ventilation
expressed as a function of work rate. Empty circles show results from the
control group; ﬁlled circles show results from CP group. Data are mean ± SD.
Number of individual values averaged per data point varies depending on
number of participants who achieved the work rate; individuals’ maximum
work rates are reported in Table 1. Horizontal lines indicate that each un-
derlying average value for the CP patients differs signiﬁcantly from the
corresponding value for the control participants. *P < 0.05; **P < 0.01.
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a high proportion of such ﬁbers. However, this hypothesis was
not supported by the biopsy results, which demonstrated almost
identical proportions of ﬁber types in the CP patients and the
normal controls.
A further possibility is that CP patients are limited in their
exercise capacity not by the availability of oxygen but rather by
their capacity to use oxygen. This diminished capacity could arise
through limitations in substrate supply to the tricarboxylic acid
cycle in a manner similar to that of the acetyl group deﬁcit in
normal humans at the start of exercise (22, 23). In particular,
production of acetyl-CoA requires the activation of PDC, which
is tightly regulated through an inactivation/activation cycle con-
trolled by kinases (PDK1-4) and phosphatases (PDP1-2), re-
spectively. In the skeletal muscle biopsies from CP patients, we
detected signiﬁcant elevations in transcript for PDK1, PDK2,
and PDK4 (the last two being the predominant isoforms of the
kinase in skeletal muscle) (24, 25). This ability of HIF to sup-
press oxidative metabolism is consistent with observations made
in mice lacking HIF-1α in skeletal muscle; these mice had an
increased level of exercise endurance associated with a lower
level of lactate and a lower level of mRNA for PDK1 (26). Al-
though there is a mouse model of CP (27, 28), no metabolic
phenotype has been reported. Apart from PDK, we also ob-
served elevated levels of transcript for two other known HIF-
regulated genes (PFKM and PKM) (29, 30), but transcripts for
other HIF-target genes were not signiﬁcantly altered in CP
patients. This result may have arisen simply as a type II error
because of our limited number of patients. Overall, although
PDCt activity did not differ signiﬁcantly between the two groups,
alterations in the expression of its regulatory kinase or phos-
phatase enzymes nevertheless might explain the observed ab-
normalities in skeletal muscle energy metabolism.
In cell culture, an increased level of HIF-1 has been associated
with mitochondrial autophagy (16). Because there is a strong
relationship between total mitochondrial volume and maximal
oxygen uptake capacity (31), a further possible explanation of the
reduced exercise capacity and enhanced lactate production of
the CP patients is a reduction in mitochondrial volume. How-
ever, the lack of any difference between groups in the markers of
mitochondrial volume (GluDH and CS activities) provides no
evidence to support a reduced mitochondrial volume in the CP
patients. In skeletal muscle of HIF-1α–null mice, the number of
mitochondria also was not altered (32).
Table 2. Results from the skeletal muscle biopsy for Chuvash
polycythemia patients and control participants
Participant Glycogen* PDCt† GluDH† CS† HAD† GlyPDH† MHC MLC
Control #1 384 9.1 9.9 39.0 20.2 4917 0.42 0.17
Chuvash #1 406 4.8 7.9 48.5 17.5 6147 0.40 0.10
Control #2 430 3.8 6.7 36.2 16.3 6421 2.00 0.90
Chuvash #2 251 2.0 5.4 46.3 16.0 6246 0.55 0.18
Control #3 346 7.9 4.0 37.2 7.4 3597 0.63 0.13
Chuvash #3 323 4.5 9.4 65.7 27.8 6297 0.17 0.33
Control #4 601 13.0 14.3 118.1 36.0 5868 0.15 0.08
Chuvash #4 349 5.5 6.6 36.1 27.8 4773 0.36 0.05
Control #5‡ 500 4.4 6.9 32.4 10.4 6072
Chuvash #5 364 7.8 5.4 27.9 9.8 4968 0.50 0.10
Control
Mean 452 7.6 8.3 52.6 18.1 5375 0.80 0.32
SD 101 3.7 3.9 36.7 11.2 1140 0.82 0.39
Chuvash
Mean 339 4.9 7.0 44.9 19.8 5686 0.40 0.15
SD 57 2.1 1.7 14.3 7.9 750 0.15 0.11
P value 0.08 0.07 0.58 0.73 0.85 0.69 0.33 0.50
CS, citrate synthase activity; GluDH, glutamate dehydrogenase activity;
GlyPDH, glyceraldehyde-3-phosphate dehydrogenase activity; HAD, 3-hydroxy-
acyl-coA dehydrogenase activity; MHC, myosin heavy chain; MLC, myosin light
chain; PDCt, pyruvate dehydrogenase complex total activity.
*mmol glucosyl units kg−1 dry muscle.
†nmol acetyl-CoA min−1 mg−1 protein.
‡Insufﬁcient material for MHC and MLC determination.
Table 3. Changes in mRNA expression levels in Chuvash
polycythemia patients relative to control participants
Gene name Fold change 95% CI P value
HK1 1.4 0.8–2.1 0.06
HK2 0.76 0.27–2.18 0.57
PFKM 1.4 1.1–2.0 0.04
M1-PKM 1.8 1.2–2.8 0.01
M2-PKM 1.8 1.1–3.0 0.04
PDP1 0.55 0.27–1.11 0.09
PDP2 0.67 0.30–1.48 0.28
PDK1 2.0 1.1–3.5 0.03
PDK2 1.9 1.3–2.7 0.004
PDK3 1.2 0.6–2.1 0.53
PDK4 5.5 1.7–18.4 0.01
LDHA 1.5 0.8–2.7 0.17
Expression data at the mRNA level for hexokinase 1 isoforms 1 (HK1) and
2 (HK2), muscle phosphofructokinase (PFKM), M1 isoform of muscle pyru-
vate kinase (M1-PKM), M2 isoform of muscle pyruvate kinase (M2-PKM),
pyruvate dehydrogenase phosphatase isoforms 1 (PDP1) and 2 (PDP2), pyru-
vate dehydrogenase kinase isoforms 1 (PDK1), 2 (PDK2), 3 (PDK3), and 4
(PDK4), and lactate dehydrogenase A (LDHA). The 95% conﬁdence interval
(95% CI) is reported for each fold change.
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Fig. 3. Results from CP group and control group for 31P MRS on calf muscle:
(A) PCr concentration, (B) Pi concentration, and (C) pH as a function of time.
The vertical broken lines indicate the onset and offset of the 5-min plantar-
ﬂexion exercise sessions, and the associated black bars indicate the power
outputs (3, 4, and 5 W). Empty circles show results from the control group
(n = 5); ﬁlled circles show results from the CP group (n = 5). Values are minute
averages ± SD. Hatched horizontal bars indicate periods of signiﬁcant dif-
ference (P < 0.05) between groups.
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A further ﬁnding in cell culture is that HIF-1 may regulate the
expression of cytochrome oxidase subunit 4 isoforms (15). It thus
is possible that their expression differs in the CP patients and
controls, and this difference could affect the efﬁciency with
which they are able to consume oxygen within the muscle. Our
muscle biopsy analyses were limited by the amount of tissue
available, and we were unable to assess this possibility.
Given the magnitude of the effects of CP on skeletal muscle
metabolism during exercise, there were remarkably few aberra-
tions in glucose, lactate, and pyruvate metabolism after meal in-
take in CP patients. Glucose homeostasis after meal intake was
normal. Notably, lactate uptake in the forearm in CP patients was
no different from that in control participants in both the resting
pre- and postprandial states. Arterial blood lactate concentration
increased more in CP patients after meal intake, but the origin of
this lactate is not known. Tissues with a net production of lactate
are brain, intestine, blood cells, skin, and adipose tissue (33–35),
whereas kidney (renal cortex) and liver remove lactate (36).
Skeletal muscle will extract or produce lactate depending on
metabolic state and muscular workload. There was no association
between the rise in plasma lactate and hematocrit (higher in some
CP patients than in controls), suggesting that generation of lactate
from blood does not contribute to the difference between the
groups. The production of lactate from skin also probably can be
assumed to be constant. The contribution of lactate production
from adipose tissue was not likely to have been very signiﬁcant in
a whole-body perspective, at least not in these groups of moder-
ately lean people. Therefore the postprandial rise in lactate would
seem more likely to depend on a CP-speciﬁc effect on intestinal
lactate production, on a reduction in postprandial hepatic lactate
clearance, or a combination of both. Changes in pyruvate con-
centration mirrored those of lactate, and there were no differ-
ences between groups in the lactate/pyruvate ratios in blood; these
ﬁndings are consistent with there being no major disturbance of
the cellular cytosolic redox state.
The meal intake gave us the opportunity to examine the
postprandial rise in plasma insulin to search for an insulin-
secretion defect. Such defects have been reported recently in
mice with a conditional deletion of VHL within pancreatic β cells
(37–39). Because the rise of meal-stimulated insulin appeared
normal and also appeared to control postprandial plasma glu-
cose concentrations within a normal range, we conclude that the
subtle systemic VHL deﬁcit present in CP patients causes no
gross abnormality in insulin secretion.
With respect to their cardiopulmonary phenotype, CP patients
generally appear to phenocopy sea-level natives who have been
acclimatized to the hypoxia of high altitude (20). In relation to
exercise, however, the predominant view has been that both
acclimatized sea-level natives and high-altitude natives accu-
mulate less lactate in the blood during exercise and have lower
peak values for lactate after exhaustive exercise than do un-
acclimatized individuals (40, 41). This situation has been termed
the “lactate paradox” (41–43). In contrast, our CP patients ex-
hibit the opposite effect. However, not all studies have detected
the reduction in lactate accumulation during exercise following
acclimatization (44, 45), and the existence of the lactate paradox
is a matter of debate (43, 46–50). In a similar manner, there is
a debate as to whether there are any beneﬁts associated with
a “live high, train low” regimen for endurance athletes other
than those that may arise from the associated erythrocytosis (51).
Our results suggest that sustained activation of the HIF pathway
in humans is more likely to be deleterious to such performance.
Finally, the comparison between CP and reduced oxygen avail-
ability should not be drawn too closely, because oxygen not only
affects the levels of HIF but is itself a key substrate in metabo-
lism. Metabolic changes also could affect 2-oxoglutarate con-
centrations, and these concentrations in turn affect the level of
HIF (52, 53).
In summary, CP is a subtle genetic abnormality that results in
a modest increase in expression of HIF-regulated gene products in
the absence of hypoxia. In this study, with our limited number of
patients, we were unable to detect some of the effects that might
be predicted from the much more powerful manipulations of the
HIF system that can be undertaken in cell culture. Nevertheless,
despite the subtle nature of the CP defect, major effects on overall
metabolism could be detected as soon as metabolism was sufﬁ-
ciently stressed. These ﬁndings emphasize that HIF plays an im-
portant role in the overall regulation of metabolic function and
that other mechanisms within the intact organism do not com-
pensate fully for the metabolic effects of the CP modiﬁcation.
Materials and Methods
Participants. Five CP patients andﬁve healthy control participants took part in
the study. Table 1 shows the characteristics of individual participants. CP
patients were identiﬁed from previous studies (20, 54). Control participants
were recruited by advertisement. Each CP patient was homozygous for the
classic Chuvash mutation (19) and had been treated with long-term vene-
section to maintain a hematocrit near normal. Nonetheless, two patients
presented with high hematocrits (62% and 64%) on the ﬁrst day of the
experiments. No patient had undergone venesection within several weeks of
the experiment. The patients had no other medical disorders, had no history
of complications, and were asymptomatic except for occasional headaches
and tiredness. The number of CP patients included in the study was limited
by the rarity of this condition in the United Kingdom. Control participants
were chosen to match CP patients for gender and, as far as possible, for
a combination of age, physical ﬁtness (based on the amount of exercise
taken each week), and body build. Each participant was informed about the
aims, procedure, and details of the study and signed a written informed
consent form before taking part in the experiments. The study conformed to
the Declaration of Helsinki and was approved by the Oxfordshire Research
Ethics Committee.
Experimental Procedure. The experiments were performed over 2 consec-
utive days and included an incremental bicycle exercise test to exhaustion,
a small muscle mass exercise test, a standard meal tolerance test, and
a muscle biopsy. These tests were ordered chronologically to minimize the
effects of each test on the others as follows. On the morning of the
ﬁrst day, participants undertook the small muscle mass (calf) light exercise
tests for biochemical investigation using 31P MRS. In the afternoon muscle
biopsies were taken from the nonexercised vastus lateralis after in-
ﬁltration of the biopsy area with 1% lidocaine. In the evening participants
were given a low-fat meal. On the second day, the standardized meal
tolerance test was administered; arteriovenous differences in metabolites
concentrations were measured before and for 5 h after the consumption
of the meal. The second day ended with the incremental exercise test to
exhaustion on the cycle ergometer. Participants fasted overnight from
8:00 PM before each experimental day. They also were asked to avoid
vigorous exercise and alcohol and caffeine consumption for 48 h before
the experiments.
The methods for each test followed standard procedures. Detailed
methodology for the incremental exercise test to exhaustion, small muscle
mass exercise for investigation with MRS, the standard meal tolerance test,
muscle biopsy analyses, and statistical analysis are described in SI Materials
and Methods.
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SI Materials and Methods
Incremental Exercise Test to Exhaustion. Participants’ exercise ca-
pacity was measured through an incremental exercise test to
exhaustion on a modiﬁed, electrically braked cycle ergometer
(Mijnhardt KEM3; Cardiokinetics). At the start of exercise par-
ticipants were given 30 s to achieve the required pedaling frequency
(∼65 revolutions per min) before the workload was increased by
20W per min until exhaustion. Exhaustion was deﬁned as the point
at which the participants could no longer maintain the required
pedaling frequency. Venous blood was sampled at the end of each
work load (i.e., once per minute) to measure venous blood lactate
concentration. Participants breathed through a mouthpiece, with
their nose occluded. Respired gases were sampled through a cath-
eter and analyzed continuously by mass spectrometry. Respiratory
volumes were measured by means of a turbine volume-measuring
device. Breath-by-breath data were averaged for each min of ex-
ercise. Room temperature during exercise was ∼21 °C.
Small Muscle Mass Exercise for Investigation with Magnetic Resonance
Spectroscopy. Participants reported to the laboratory early on the
second day after an overnight fast. Skeletal muscle 31P magnetic
resonance spectroscopy (MRS) was performed in a Siemens Tim
Trio 3.0-Tesla magnet with a 60-cm clear bore, interfaced with
Syngo software. The participants were positioned supine and
a dual-tuned 31P and 1H 6-cm-diameter surface coil was secured
under the right calf muscle. The right foot was fastened to a cus-
tom-built nonmagnetic plantar ﬂexion exercise apparatus and was
immobilized with the leg straightened. The plantar ﬂexion exercise
apparatus was similar to the one previously described by Tran
et al. (1). The exercise protocol consisted of 3 min of rest followed
by three 5-min periods of exercise interspersed with 7-min recovery
periods. The work rates for subsequent exercise periods were 3 W,
4 W, and 5 W. The calf was exercised at 1 Hz, in time to a digital
metronome, which was played through the magnet room speakers.
Participants were monitored continuously, and none had difﬁculty
keeping time or completing the exercise.
Transverse gradient echo scout images of the lower leg were
acquired to ensure correct positioning of the participant’s leg and
to select a region of interest within the calf muscle for localized
shimming. Three baseline scans were acquired to allow corrections
for partial saturation caused by the rapid magnetic pulse repeti-
tion time and nuclear Overhauser enhancement (NOE). The data
acquisition consisted of a series of 444 31P spectra acquired
throughout the exercise protocol described above with a temporal
resolution of 5 s. The acquisition parameters were as follows: 500
ms repetition time, 0.35 ms short echo time, 4,000 Hz spectral
width, 10 averages, 1,024 data points, nominal 25° ﬂip angle, and
10 rectangular NOE pulses, with a pulse duration of 10 ms, an
interpulse delay of 10 ms, and an excitation ﬂip angle of 180°.
After phasing and baseline correction, spectra peaks were ﬁtted
using the automated AMARES algorithm, within the jMRUI
software package (version 2.2) (2, 3). Absolute millimolar con-
centrations of phosphorus metabolites were calculated assuming
that the concentration of cytosolic ATP at rest is 8.2 mM; this
commonly used standard concentration is based on values ex-
tensively reported in the published literature (4).
Intramuscular pHwas calculated on the basis of the chemical shift
(σ) of phosphate relative to phosphocreatine in parts per million:
pH ¼ 6:75þ log10

σ− 3:27
5:63− σ

[1]
Standard Meal Tolerance Test. The standardized meal consisted of
Rice Krispies (Kellogg Company) semiskimmed milk, dried
skimmed milk powder, fresh orange juice, and a chocolate drink.
The chocolate drink contained cocoa powder (2 g), palm oil
(14 g), safﬂower oil (14 g), emulsiﬁer (0.4 g), sweetener (1.2 g),
and hot water (35.5 g). The caloric content of the ﬁber-free
standard meal was scaled to each participant’s body weight and
height, so that it corresponded to about 40% of the daily energy
requirement. The proportions of energy sources were constant
for all participants. Protein provided 13% of the total energy
intake, fat 38%, and carbohydrates 49%.
Participants rested on a bed throughout the study. Cannulae
were inserted under local anesthetic into both the femoral artery
and retrogradely into a vein draining the deep structures of the
forearm. These cannulae were kept patent by a slow infusion of
0.9% (wt/vol) saline. Two sets of blood samples were taken 30min
apart in the fasting state. Following the standardized meal, paired
arterial and venous blood samples were taken at varying time
points over the subsequent 5 h. Two minutes before each sample
was taken, a wrist cuff was inﬂated to 200 mm Hg to prevent
contamination of the venous blood from the forearm vein by
blood from the hand. Blood samples were used to quantify
glucose, insulin, lactate, and pyruvate as described elsewhere (5,
6). Forearm muscle blood ﬂow was assessed by strain-gauge
plethysmography (7).
Muscle Biopsy Analyses.A portion of frozen muscle tissue was used
to determine muscle ﬁber composition. The muscle was ho-
mogenized in a pyrophosphate extraction buffer (pH 9.5) sup-
plemented with protease and phosphatase inhibitors (Sigma).
Actomyosin was extracted from the homogenate by vibrating for 1
h in a cold room (0 °C) and then centrifuging at 10,000 × g for 10
min at 2–8 °C. The supernatant was mixed 1:1 with standard
Laemmli sample buffer, boiled, and then run on a 5% SDS/
PAGE gel for 18 h at 70 V to separate the myosin heavy-chain
isoforms. The bands were identiﬁed with silver staining. The gel
then was scanned using a Duo Scan T1200 Agfa scanner, and
bands were quantiﬁed using the Quantity One program (Bio-
Rad). Optical densities were adjusted by subtracting the local
background. All values were normalized to the intensity of the
actin band. Estimation of muscle ﬁber composition using this
approach has been shown to be in good agreement with a stan-
dard histochemical approach for determining ﬁber composition
on muscle sections (8).
A second portion of the frozen muscle was freeze dried, dis-
sected free of visible connective tissue, and powdered. Muscle
glycogen content of this powdered tissue was measured using
a modiﬁed version of the spectrophotometric method of Harris
et al. (9).
A further portion of the frozen muscle was used to determine
pyruvate dehydrogenase complex total activity (PDCt), that being
the total (dephosphorylated) active form of the complex. Brieﬂy,
PDCt activity was assayed in a buffer containing sucrose, Tris,
EDTA, with Mg2+, Ca2+, and dichloroacetate added to activate
the pyruvate dehydrogenase complex (PDC) phosphatase and
inhibit PDC kinase, respectively. PDCt was expressed as rate of
acetyl-CoA formation [nmol · (min · mg protein)−1] at 37 °C using
a radioactive substrate. Further details are as described else-
where (10).
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Another portion of muscle was homogenized on ice in a so-
lution containing KH2PO4 50 mmol L
−1, EDTA 1 mmol L−1, and
Triton X-100 0.05% using a glass homogenizer. The muscle ex-
tract then was centrifuged at 20,000 × g for 3 min, and the su-
pernatant was used to measure the activities of glutamate
dehydrogenase, citrate synthase, 3-hydroxy-acyl-CoA dehydro-
genase, and glyceraldehyde-3-phosphate dehydrogenase, as
described by Opie and Newsholme (11) and Zammit and
Newsholme (12). Protein concentration was determined using
Peterson’s method (13).
A ﬁnal portion of muscle from the Chuvash polycythemia (CP)
patients was used for quantitative RT-PCR. Because there was
not enough material from the matched control samples, other
biopsies taken from healthy adult participants were used for this
analysis. The assays used Taqman chemistry and were undertaken
on an ABI Prism 7000 sequence detector (Applied Biosystems)
according to the manufacturer’s protocol. Hydroxymethyl bilane
syllane was used as the internal control.
Statistical Analysis.Differences between the CP patients group and
the control participants group were assessed by means of two-
tailed Student’s paired t test; pairing was undertaken based on
age, gender, height, weight, and weekly level of physical activity.
For the quantitative RT-PCR results for which there were no
paired control samples, an unpaired t test was used. Statistical
signiﬁcance was set at P < 0.05. Variables are presented as means
± SD, unless otherwise stated.
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Fig. S1. SDS/PAGE analysis of myosin heavy-chain isoforms after silver staining. Myosin heavy- chain isoforms (MHC-I, MHC-IIA, MHC-IIX, MHC-IIB) in vastus
lateralis muscle were obtained from CP patients (lanes 2, 4, 6, 9, 10) and control participants (lanes 1, 3, 7, 8). Fiber type did not differ signiﬁcantly between the
two groups. The proportion of ﬁbers type I, IIA, IIX, and IIB for the control group were 19.8 ± 2.4%, 25.7 ± 2.1%, 35.4 ± 4.9%, and 19.1 ± 2.9%, respectively,
and for the CP group were 17.2 ± 2.5%, 23.9 ± 1.4%, 31.9 ± 2.9%, and 27.0 ± 2.8%, respectively.
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Fig. S2. Results from Chuvash polycythemia patients and control participants for arterial (A) glucose, (B) insulin, (C) pyruvate, and (D) lactate and forearm (E)
blood ﬂow, (F) glucose uptake, and (G) lactate uptake measured through the standard meal tolerance test. Empty circles show results from the control group;
ﬁlled circles show results from the Chuvash polycythemia group. Data are mean ± SD. Values are for n = 5, apart from lactate for the control group where n = 3,
at times −30, 20, 150, and 240 min. *P < 0.05.
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